These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8834061)

  • 1. Female hormone therapy and the risk of developing or exacerbating systemic lupus erythematosus or rheumatoid arthritis.
    Liang MH; Karlson EW
    Proc Assoc Am Physicians; 1996 Jan; 108(1):25-8. PubMed ID: 8834061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
    Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
    Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus.
    Holroyd CR; Edwards CJ
    Climacteric; 2009 Oct; 12(5):378-86. PubMed ID: 19591008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus.
    Meier CR; Sturkenboom MC; Cohen AS; Jick H
    J Rheumatol; 1998 Aug; 25(8):1515-9. PubMed ID: 9712093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal estrogen replacement therapy and risk of developing systemic lupus erythematosus or discoid lupus.
    Petri M
    J Rheumatol; 1999 Mar; 26(3):752. PubMed ID: 10090197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormonal therapy in systemic lupus erythematosus].
    Kaliterna DM; Krstulović DM; Radić M
    Reumatizam; 2009; 56(2):41-3. PubMed ID: 20429261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogen use in systemic lupus erythematosus].
    Ketari S; Cherif O; Boussema F; Kochbati S; Ben Dhaou B; Rokbani L
    Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus and hormone replacement therapy.
    Gompel A; Piette JC
    Menopause Int; 2007 Jun; 13(2):65-70. PubMed ID: 17540136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.
    Hochman J; Urowitz MB; Ibañez D; Gladman DD
    Lupus; 2009 Apr; 18(4):313-7. PubMed ID: 19276299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy in systemic lupus erythematosus.
    Kreidstein S; Urowitz MB; Gladman DD; Gough J
    J Rheumatol; 1997 Nov; 24(11):2149-52. PubMed ID: 9375875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
    Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
    Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue diseases, arthritis require special patient counseling.
    Neinstein LS; Katz B
    Contracept Technol Update; 1985 Jul; 6(7):100-2. PubMed ID: 12280147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study.
    Doran MF; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Feb; 31(2):207-13. PubMed ID: 14760786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal estrogen therapy and selected (less-often-considered) disease outcomes.
    Barrett-Connor E
    Menopause; 1999; 6(1):14-20. PubMed ID: 10100175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden.
    Sundquist K; Li X; Hemminki K; Sundquist J
    Arch Gen Psychiatry; 2008 May; 65(5):501-7. PubMed ID: 18458201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.